An Informatics Consult has been proposed in which clinicians request novel evidence from large scale health data resources, tailored to the treatment of a specific patient, with return of results in clinical timescales. However, the availability of such consultations is lacking. We seek to provide an Informatics Consult for a situation where a treatment indication and contraindication coexist in the same patient, i.e., anti-coagulation use for stroke prevention in a patient with both atrial fibrillation (AF) and liver cirrhosis. We examined four sources of evidence for the effect of warfarin on stroke risk (efficacy) or all-cause mortality (safety) from: (i) randomised controlled trials (RCTs), (ii) meta- analysis of prior observational studies, (iii) trial emulation (using population electronic health records (N = 3,854,710) and (iv) genetic evidence (Mendelian randomisation). We developed prototype forms to request an Informatics Consult and return of results in electronic health record systems. We found 0 RCT reports and 0 trials recruiting for patients with AF and cirrhosis. We found broad concordance across the three new sources of evidence we generated. Meta-analysis of prior observational studies showed that warfarin use was associated with lower stroke risk (hazard ratio [HR] = 0.71). In a target trial emulation, warfarin was associated with lower all-cause mortality (HR = 0.61) and ischaemic stroke (HR = 0.27). Mendelian randomisation served as a drug target validation where we found that lower levels of vitamin K1 (warfarin is a vitamin K1 antagonist) are associated with lower stroke risk. A pilot survey with an independent sample of 34 clinicians revealed that 85% of clinicians found information on prognosis useful and that 79% thought that they should have access to the Informatics Consult as a service within their healthcare systems. We identified candidate steps for automation to scale evidence generation and to accelerate the return of results within clinical timescales.
Poster discussion hub abstracts from biparietal diameter and abdominal circumference using the eSnurra algorithm. Mean fetal weight gain/day was calculated as the difference between birthweight and estimated fetal weight in the second trimester, and thereafter related to the remaining days in pregnancy from the ultrasound examination to delivery. Results: We observed a significant association between mean flow calculated from PixelFlux and weight gain/day (r =0.33; p =0.02) as presented in the Figure. The correlations remained significant after adjusting for maternal age, BMI, parity and systolic blood pressure (p =0.01 and p =0.02, respectively). Conclusions: We found a significant association between total blood flow based on PixelFlux and fetal weight-gain/day. The PixelFlux method might be a promising tool in predicting birthweight.Supporting information can be found in the online version of this abstract P21.08 Diagnosis of metabolic risk during pregnancy by body mass index (BMI): does a better method exist? Preliminary results
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.